
Sign up to save your podcasts
Or


Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Hashem El-Serag from the Department of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA, on the paper "Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis" published in paper copy in Gut in June 2024.
By BMJ Group4.1
77 ratings
Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Hashem El-Serag from the Department of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA, on the paper "Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis" published in paper copy in Gut in June 2024.

137 Listeners

317 Listeners

498 Listeners

35 Listeners

48 Listeners

68 Listeners

5 Listeners

5 Listeners

3 Listeners

1 Listeners

3 Listeners

9 Listeners

40 Listeners

14 Listeners

1 Listeners

50 Listeners

0 Listeners

6 Listeners

31 Listeners

16 Listeners

3 Listeners

3,347 Listeners

3 Listeners

22 Listeners

1,145 Listeners

195 Listeners

515 Listeners

23 Listeners

367 Listeners

248 Listeners

370 Listeners

17 Listeners

0 Listeners